Skip to main content

Advertisement

Log in

The effect of adding Montelukast to oxybutynin on daily urination in children with pollakiuria: a randomized clinical trial

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Pollakiuria is defined as a change in the pattern of daily urination. Students have mentioned wetting their pants at school as the third tragic event after the death of a parent or going blind. In this study, the effect of adding Montelukast to oxybutynin on the improvement of urinary symptoms of patients with pollakiuria was studied.

Materials and methods

This study was a pilot clinical trial in which children with pollakiuria aged 3–18 years old were included. These children were randomly divided into two groups of intervention (Montelukast plus oxybutynin) and the control group (only oxybutynin). At the beginning and the end of the study (after 14 days), mothers were asked about the frequency of daily urination. Finally, the gathered data were compared between two groups.

Results

In the present study, 64 patients were examined in two intervention and control groups (32 in each group). The results revealed that although significant changes were observed in both groups before and after intervention, the average changes in the intervention group were significantly higher (p = 0.014).

Conclusion

The results of this study showed that adding montelukast to oxybutynin has a significant decrease in frequency of daily urination in patients with pollakiuria, although further studies are recommended in this area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Availability of data and materials

The datasets used and analyzed during the current study are available to be collected from the corresponding author on reasonable request.

References

  1. Bergmann M, Corigliano T, Ataia I, Renella R, Simonetti GD, Bianchetti MG, von Vigier RO (2009) Childhood extraordinary daytime urinary frequency-a case series and a systematic literature review. Pediatr Nephrol 24(4):789–795. https://doi.org/10.1007/s00467-008-1082-9

    Article  PubMed  Google Scholar 

  2. Watemberg N, Shalev H (1994) Daytime urinary frequency in children. Clin Pediatr 33(1):50–53

    Article  CAS  Google Scholar 

  3. Sureshkumar P, Jones M, Cumming R, Craig J (2009) A population based study of 2856 school-age children with urinary incontinence. J Urol 181(2):808–815. https://doi.org/10.1016/j.juro.2008.10.044. (Discussion 815-806)

    Article  PubMed  Google Scholar 

  4. Kajiwara M, Inoue K, Kato M, Usui A, Kurihara M, Usui T (2006) Nocturnal enuresis and overactive bladder in children: an epidemiological study. Int J Urol 13(1):36–41. https://doi.org/10.1111/j.1442-2042.2006.01217.x

    Article  PubMed  Google Scholar 

  5. Hellström AL, Hanson E, Hansson S, Hjälmås K, Jodal U (1990) Micturition habits and incontinence in 7-year-old Swedish school entrants. Eur J Pediatr 149(6):434–437. https://doi.org/10.1007/BF02009667

    Article  PubMed  Google Scholar 

  6. Hägglöf B, Andrén O, Bergström E, Marklund L, Wendelius M (1998) Self-esteem in children with nocturnal enuresis and urinary incontinence: improvement of self-esteem after treatment. Eur Urol 33(Suppl 3):16–19. https://doi.org/10.1159/000052236

    Article  PubMed  Google Scholar 

  7. Ollendick TH, King NJ, Frary RB (1989) Fears in children and adolescents: reliability and generalizability across gender, age and nationality. Behav Res Ther 27(1):19–26. https://doi.org/10.1016/0005-7967(89)90115-0

    Article  CAS  PubMed  Google Scholar 

  8. Bower WF (2008) Self-reported effect of childhood incontinence on quality of life. J Wound, Ostomy, Continence Nurs 35(6):617–621. https://doi.org/10.1097/01.won.0000341476.71685.78

    Article  PubMed  Google Scholar 

  9. Bower WF, Moore KH, Shepherd RB, Adams RD (1996) The epidemiology of childhood enuresis in Australia. Br J Urol 78(4):602–606. https://doi.org/10.1046/j.1464-410x.1996.13618.x

    Article  CAS  PubMed  Google Scholar 

  10. Bauer SB, Retik AB, Colodny AH, Hallett M, Khoshbin S, Dyro FM (1980) The unstable bladder in childhood. Urol Clinics N Am 7(2):321–336

    Article  CAS  Google Scholar 

  11. Fitzgerald MP, Thom DH, Wassel-Fyr C, Subak L, Brubaker L, Van Den Eeden SK, Brown JS (2006) Childhood urinary symptoms predict adult overactive bladder symptoms. J Urol 175(3 Pt 1):989–993. https://doi.org/10.1016/s0022-5347(05)00416-7

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kuh D, Cardozo L, Hardy R (1999) Urinary incontinence in middle aged women: childhood enuresis and other lifetime risk factors in a British prospective cohort. J Epidemiol Community Health 53(8):453–458. https://doi.org/10.1136/jech.53.8.453

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Tsai ML, Lin HC, Yen CH, Ku JT, Sung SY, Chang H (2022) Increased Risk of Tourette syndrome with Leukotriene modifier use in children with allergic diseases and asthma: a nationwide population-based study. Children. https://doi.org/10.3390/children9111607

    Article  PubMed  PubMed Central  Google Scholar 

  14. Heydari S, Khoshmohabat H, Akerdi AT, Ahmadpour F, Paydar S (2022) Evaluating the effect of montelukast tablets on respiratory complications in patients following blunt chest wall trauma: a double-blind, randomized clinical trial. Chin J Traumatol. https://doi.org/10.1016/j.cjtee.2022.10.002

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, Holgate ST, Davies DE (2005) Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201(6):937–947. https://doi.org/10.1084/jem.20041901

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST (1995) Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 151(3 Pt 1):879–886. https://doi.org/10.1164/ajrccm/151.3_Pt_1.879

    Article  CAS  PubMed  Google Scholar 

  17. van Adelsberg J, Philip G, Pedinoff AJ, Meltzer EO, Ratner PH, Menten J, Reiss TF (2003) Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy 58(12):1268–1276. https://doi.org/10.1046/j.1398-9995.2003.00261.x

    Article  PubMed  Google Scholar 

  18. Virchow JC, Bachert C (2006) Efficacy and safety of montelukast in adults with asthma and allergic rhinitis. Respir Med 100(11):1952–1959. https://doi.org/10.1016/j.rmed.2006.02.026

    Article  PubMed  Google Scholar 

  19. WajihUllah M, Lakhani S, Sham S, Rehman A, Siddiq W, Siddiqui T (2018) Painful bladder syndrome/interstitial cystitis successful treatment with montelukast: a case report and literature review. Cureus. 10(6):e2876. https://doi.org/10.7759/cureus.2876

    Article  Google Scholar 

  20. Schulz KF, Altman DG, Moher D, The CG (2010) CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Medicine 8(1):18. https://doi.org/10.1186/1741-7015-8-18

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kliegman RM, Toth H, Bordini BJ, Basel D (2022) nelson pediatric symptom-based diagnosis e-book, 21st edn. Elsevier Health Sciences, New York

    Google Scholar 

  22. Taherahmadi H, Yousefichaijan P, Rezagholizamenjany M, Kahbazi M, Nazari T (2019) Investigating the effect of montelukast on the pyelonephritis symptoms in children. Nephro-Urol Monthly 11(4):e96626. https://doi.org/10.5812/numonthly.96626

    Article  Google Scholar 

  23. Aigner L, Pietrantonio F, Bessa de Sousa DM, Michael J, Schuster D, Reitsamer HA, Zerbe H, Studnicka M (2020) The leukotriene receptor antagonist montelukast as a potential COVID-19 therapeutic. Front Mol Biosci. 7:610132. https://doi.org/10.3389/fmolb.2020.610132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Anderson R, Theron AJ, Gravett CM, Steel HC, Tintinger GR, Feldman C (2009) Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism. Br J Pharmacol 156(1):105–115. https://doi.org/10.1111/j.1476-5381.2008.00012.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Marques CF, Marques MM, Justino GC (2022) The mechanisms underlying montelukast’s neuropsychiatric effects—new insights from a combined metabolic and multiomics approach. Life Sci. 310:121056. https://doi.org/10.1016/j.lfs.2022.121056

    Article  CAS  PubMed  Google Scholar 

  26. Dülger EÇ, Şener G, Çetinel Ş, Ercan F, Çanillioğlu YE (2018) Protective effects of Montelukast against stress-induced degeneration of the urinary bladder. Clin Exp Health Sci 8(3):211–216. https://doi.org/10.5152/clinexphealthsci.2017.691

    Article  CAS  Google Scholar 

  27. Traut JL, Macdonald ES, Spangler ML, Saxena S (2011) Montelukast for symptom control of interstitial cystitis. Ann Pharmacother 45(9):e49. https://doi.org/10.1345/aph.1Q130

    Article  PubMed  Google Scholar 

  28. Sterrett S, Morton J, Perry D, Donovan J (2006) Eosinophilic cystitis: Successful long-term treatment with montelukast sodium. Urology 67(2):423.e419-423.e421. https://doi.org/10.1016/j.urology.2005.08.059

    Article  Google Scholar 

  29. Dobrek L, Skowron B, Baranowska A, Thor PJ (2015) The influence of montelukast on the autonomic nervous system activity in rats with cyclophosphamide-induced hemorrhagic cystitis. Curr Issues Pharm Medi Sci 28(3):170–175. https://doi.org/10.1515/cipms-2015-0066

    Article  CAS  Google Scholar 

  30. Bouchelouche K, Nordling J, Hald T, Bouchelouche P (2001) Treatment of interstitial cystitis with montelukast, a leukotriene D(4) receptor antagonist. Urology 57(6 Suppl 1):118. https://doi.org/10.1016/s0090-4295(01)01066-4

    Article  CAS  PubMed  Google Scholar 

  31. Bouchelouche K, Andersen L, Nordling J, Horn T, Bouchelouche P (2003) The cysteinyl-leukotriene D4 induces cytosolic Ca2+ elevation and contraction of the human detrusor muscle. J Urol 170(2 Pt 1):638–644. https://doi.org/10.1097/01.ju.0000076390.30043.ff

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thanks Arak University of Medical Sciences for their scientific and financial support.

Funding

This study was funded by Vice-chancellor for Research of Arak University of Medical Sciences.

Author information

Authors and Affiliations

Authors

Contributions

Study conception and design: AAS, HB, FD, PY, and AAH. Data collection, statistical expertise, analysis and interpretation of data: AAS, HB and AAH. Manuscript preparation, supervision, administrative support and critical revision of the paper: AAS, HB, FD, PY and AAH. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Amir Almasi-Hashiani.

Ethics declarations

Conflict of interest

All authors declared that they have no conflict of interest.

Ethical approval and consent to participate

All stages of research were conducted following the Declaration of Helsinki and the Ethical Statements of the Ethics Committee of Arak University of Medical Sciences. This study was approved by the Ethics Committee of Arak University of Medical Sciences (Ethical code: IR.ARAKMU.REC.1400.054). The parents or legal guardians of subjects provided written informed consent on their behalf. The children were also asked verbally if they were willing to participate in the study.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arjmand Shabestari, A., Bakhtiari, H., Dorreh, F. et al. The effect of adding Montelukast to oxybutynin on daily urination in children with pollakiuria: a randomized clinical trial. Int Urol Nephrol 55, 2139–2144 (2023). https://doi.org/10.1007/s11255-023-03673-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-023-03673-3

Keywords

Navigation